Sinus dysfunction after stent implantation in the right coronary artery immediately recovered after reflow in the sinus node artery.
No-Reflow after PPCI-A Predictor of Short-Term Outcomes in STEMI Patients.
Pantea-Roșan LR, Pantea VA, Bungau S, Tit DM, Behl T, Vesa CM, Bustea C, Moleriu RD, Rus M, Popescu MI, Turi V, Diaconu CC.
J Clin Med. 2020 Sep 12;9(9):2956. doi: 10.3390/jcm9092956.
Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu Q, Lu W, Huang YJ, Wu Q, Wang LG, Wang HB, Jiang SZ, Wang YJ.
Cell Biochem Biophys. 2013;67(3):911-4. doi: 10.1007/s12013-013-9581-0.
Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH, Kim WJ, Park DW, Choi BR, Lee SW, Kim YH, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ.
Int J Cardiol. 2010 May 28;141(2):175-81. doi: 10.1016/j.ijcard.2008.11.189. Epub 2009 Jan 13.
Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY, Lee SE, Kim SH, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.
J Cardiol. 2009 Aug;54(1):36-44. doi: 10.1016/j.jjcc.2009.03.003. Epub 2009 Apr 19.
CoO Nanoparticles Combined with MRI: Analysis of No-Reflow in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI and the Effect of Coronary Nicorandil.
Liang X, Li P, Xie W, Lin Z, Li Y, Liao W, Liu M.
Cell Mol Biol (Noisy-le-grand). 2022 Mar 31;68(3):390-401. doi: 10.14715/cmb/2022.68.3.43.
Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction.
Chen Y, Gao YF, Wang YF, Wang CJ, Du Y, Ding YH.
Clin Interv Aging. 2022 Nov 28;17:1687-1695. doi: 10.2147/CIA.S389302. eCollection 2022.
Could direct stenting reduce no-reflow in acute coronary syndromes? A randomized pilot study.
Sabatier R, Hamon M, Zhao QM, Burzotta F, Lecluse E, Valette B, Grollier G.
Am Heart J. 2002 Jun;143(6):1027-32. doi: 10.1067/mhj.2002.122509.
Predictive performance of dual modality of computed tomography angiography and intravascular ultrasound for no-reflow phenomenon after percutaneous coronary stenting in stable coronary artery disease.
Okutsu M, Horio T, Tanaka H, Akiyama M, Okimoto N, Tsubouchi T, Kawajiri K, Ohashi Y, Sumitsuji S, Ikari Y.
Heart Vessels. 2018 Oct;33(10):1121-1128. doi: 10.1007/s00380-018-1160-2. Epub 2018 Apr 11.
Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
Hong SN, Ahn Y, Hwang SH, Yoon NS, Lee SR, Moon JY, Kim KH, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
Am J Cardiol. 2007 Aug 15;100(4):631-4. doi: 10.1016/j.amjcard.2007.03.075. Epub 2007 Jun 28.
Effects of rotational atherectomy with a reduced burr-to-artery ratio on coronary no-reflow.
Sardella G, De Luca L, Adorisio R, Di Russo C, Fedele F.
Minerva Cardioangiol. 2004 Jun;52(3):209-17.
